4.8 Article

Microtubule-Based Control of Motor-Clutch System Mechanics in Glioma Cell Migration

Journal

CELL REPORTS
Volume 25, Issue 9, Pages 2591-+

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.10.101

Keywords

-

Categories

Funding

  1. NSF [ACI-1053575, 00039202]
  2. 3M Science & Technology Doctoral Fellowship
  3. University of Minnesota UROP award
  4. NIH [T32 ES007020, U54 CA210180, R01 NS073610, R01 CA172986, U54 CA 210190, R01 GM076177]
  5. NATIONAL CANCER INSTITUTE [U54CA210190, U54CA210180, R01CA172986] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073610] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Microtubule-targeting agents (MTAs) are widely used chemotherapy drugs capable of disrupting microtubule-dependent cellular functions, such as division and migration. We show that two clinically approved MTAs, paclitaxel and vinblastine, each suppress stiffness-sensitive migration and polarization characteristic of human glioma cells on compliant hydrogels. MTAs influence microtubule dynamics and cell traction forces by nearly opposite mechanisms, the latter of which can be explained by a combination of changes in myosin motor and adhesion clutch number. Our results support a microtubule-dependent signaling-based model for controlling traction forces through a motor-clutch mechanism, rather than microtubules directly relieving tension within F-actin and adhesions. Computational simulations of cell migration suggest that increasing protrusion number also impairs stiffness-sensitive migration, consistent with experimental MTA effects. These results provide a theoretical basis for the role of microtubules and mechanisms of MTAs in controlling cell migration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available